ISIS News Alert Isis Pharmaceuticals (ISIS) 65.44 01/06/2015

New Post Public Reply Private Reply Replies (0) Message Board

Jan 6, 2015 at 6:53 PM

Isis Pharmaceuticals (ISIS) 65.44 $ISIS

AOL and Gilead Sciences are big market movers
AP - 23 mins ago
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
F: 14.62 (-0.14), K.TO: 3.95 (+0.47), CS: 23.81 (-0.43), BBEP: 6.90 (+0.08), SDRL: 10.48 (-0.33), NBG: 1.58 (-0.08), CYBX: 54.36 (-3.43), JNJ: 103.28 (-0.51), ISIS: 65.44 (-2.73), KGC: 3.33 (+0.38), AOL: 46.25 (+1.51), CVEO: 3.11 (-0.32), EBIX: 18.60 (+2.32), THLD: 3.55 (-0.13), CEMP: 23.15 (-1.40), VZ: 47.04 (+0.47), XOOM: 16.82 (-0.07)

Isis Pharmaceuticals Up on Collaboration with J&J - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 33 mins ago
Isis Pharmaceuticals (ISIS) inked a global collaboration with Johnson & Johnson's (JNJ) Janssen Biotech, Inc for the discovery and development of antisense drugs for treating autoimmune disorders of the gastrointestinal tract.
BIIB: 334.65 (-2.09), JNJ: 103.28 (-0.51), ISIS: 65.44 (-2.73), AZN: 68.16 (-1.70)

Public Shame for Biotechs Not Webcasting 'JPM15' Breakout Sessions
at The Street - Tue Jan 06, 2:08PM CST
In a blow to investor transparency, an embarrassingly small number of healthcare companies are webcasting their Q&A breakout sessions at next week's J.P. Morgan Healthcare Conference.
BLUE: 95.24 (+3.19), BIIB: 334.65 (-2.09), VRTX: 117.36 (-3.67), ISIS: 65.44 (-2.73), SGEN: 31.45 (-1.60), GILD: 97.65 (+0.86), AMGN: 152.90 (-5.09), AGIO: 111.43 (+2.56), BMY: 58.48 (-0.10), CELG: 110.51 (-1.42)

Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015
at The Street - Tue Jan 06, 10:52AM CST
TheStreet's Adam Feuerstein lays down his predictions for the biotech industry for 2015.
BLUE: 95.24 (+3.19), BIIB: 334.65 (-2.09), QCOR: 93.60 (+1.52), ISIS: 65.44 (-2.73), GILD: 97.65 (+0.86), PFE: 31.42 (+0.26), VVUS: 2.94 (-0.10), JUNO: 51.66 (+5.71), BMY: 58.48 (-0.10), MNKD: 5.57 (-0.13), ARNA: 3.32 (-0.20), PBYI: 188.12 (-0.25), CELG: 110.51 (-1.42)

Company News for January 06, 2015 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Tue Jan 06, 9:10AM CST
Companies in the News are: KITE,AMGN,STI,ISIS,NPSP,GS
JNJ: 103.28 (-0.51), GS: 184.53 (-3.81), ISIS: 65.44 (-2.73), KITE: 71.45 (+1.70), NPSP: 41.05 (+2.92), STI: 39.08 (-1.16), AMGN: 152.90 (-5.09)

Critical Alerts For JetBlue, Isis Pharmaceuticals, Gold Fields, 58.com and 51job Released By InvestorsObserver
PR Newswire - Tue Jan 06, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for JBLU, ISIS, GFI, WUBA and JOBS.
WUBA: 40.57 (-1.97), JOBS: 36.62 (-0.49), ISIS: 65.44 (-2.73), GFI: 5.24 (+0.25), JBLU: 14.97 (-0.25)

Isis Pharmaceuticals (ISIS) in Focus: Stock Soars 10.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 06, 8:21AM CST
Isis Pharmaceuticals, Inc. (ISIS) was a big mover last session, as the company saw its shares rise around 11% on the day.
ISIS: 65.44 (-2.73), AFFX: 9.94 (-0.05)

Scaling New Heights: Complimentary Research on Stereotaxis, Kite Pharma, ISIS Pharma, Merck and General Motors
PR Newswire - Tue Jan 06, 7:50AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Stereotaxis (NASDAQ: STXS), Kite Pharma (NASDAQ: KITE), ISIS Pharma (NASDAQ: ISIS), Merck (NYSE: MRK), and General Motors (NYSE: GM). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
ISIS: 65.44 (-2.73), KITE: 71.45 (+1.70), MRK: 60.32 (+2.28), GM: 34.85 (+0.52), STXS: 1.70 (-0.18)

New business head at Isis
Seeking Alpha - at Seeking Alpha - Tue Jan 06, 6:01AM CST

ISIS: 65.44 (-2.73)

Isis Pharmaceuticals Appoints Paula Soteropoulos As President And Chief Executive Officer Of Akcea Therapeutics
PR Newswire - Tue Jan 06, 6:00AM CST
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today the appointment of Paula Soteropoulos as president and chief executive officer (CEO) of Akcea Therapeutics, the Isis-owned, lipid franchise subsidiary responsible for the development and commercialization of Isis' lipid drugs, ISIS-APOCIIIRx, ISIS-APO(a)Rx, ISIS-ANGPTL3Rx,and their more potent LICA follow-ons.
ISIS: 65.44 (-2.73)

Jim Cramer's Top Stock Picks: INTC UNH HD MSFT CSCO ISIS
at The Street - Tue Jan 06, 5:00AM CST
Cramer is bullish about a lot of stocks going into 2015 including Microsoft, Cisco and Isis Pharmaceuticals.
HD: 100.95 (-0.31), ISIS: 65.44 (-2.73), UNH: 98.92 (-0.20), MSFT: 45.65 (-0.68), INTC: 35.28 (-0.67), CSCO: 27.05 (-0.01)

Isis Pharmaceuticals to discover and develop RNA-targeted therapeutics for autoimmune diseases in the GI Tract in partnership with Janssen
M2 - Tue Jan 06, 4:02AM CST
Drug company Isis Pharmaceuticals (NasdaqGS:ISIS) reported on Monday the launch of a global collaboration to discover and develop antisense drugs to treat autoimmune disorders of the gastrointestinal (GI) tract in three programmes in collaboration with Janssen Biotech.
ISIS: 65.44 (-2.73)

Isis Pharmaceuticals hires Sarah Boyce as its chief business officer
M2 - Tue Jan 06, 3:53AM CST
Novel drugs company Isis Pharmaceuticals (NasdaqGS:ISIS) disclosed on Monday the election of Sarah Boyce as its chief business officer as well as as a member of its executive leadership team.
ISIS: 65.44 (-2.73)

Jim Cramer's 'Mad Money' Recap: My 10 Ways to Make Your 2014 Gains Continue in 2015
at The Street - Mon Jan 05, 7:27PM CST
Tried and true conventional wisdom seemed to be best strategy last year, Cramer says.
SWIR: 44.77 (-2.21), CY: 13.69 (-0.53), HD: 100.95 (-0.31), PRU: 85.44 (-1.81), UNH: 98.92 (-0.20), INTC: 35.28 (-0.67), SLB: 81.72 (-1.63), SBUX: 79.23 (-0.65), ISIS: 65.44 (-2.73), S: 4.19 (-0.02), CVS: 94.23 (+0.07), MSFT: 45.65 (-0.68), AAPL: 106.26 (+0.01), SLCA: 24.26 (-0.59), CSCO: 27.05 (-0.01), TRV: 103.24 (-0.93)

Isis Pharmaceuticals Appoints Sarah Boyce As Chief Business Officer
PR Newswire - Mon Jan 05, 5:00PM CST
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that Sarah Boyce has joined the company as chief business officer. In this newly created position, Ms. Boyce will provide strategic leadership from a commercial background and lead Isis' corporate development activities, including corporate communications, business development, patient advocacy, competitive intelligence and alliance management. Ms. Boyce will also serve as a member of Isis' executive leadership team.
ISIS: 65.44 (-2.73)

Isis inks development deal with J&J
Seeking Alpha - at Seeking Alpha - Mon Jan 05, 12:48PM CST

JNJ: 103.28 (-0.51), ISIS: 65.44 (-2.73)

Isis Pharma To Develop GI Drugs With J&J
at Investor's Business Daily - Mon Jan 05, 12:17PM CST
Biotech Isis Pharmaceuticals (ISIS) leapt 10% to a new high above 68 In the stock market today after it signed a licensing deal with Johnson & Johnson worth up to $835 million. J&J's (JNJ) Janssen Biotech arm agreed to pay $35 million upfront and up...
BIIB: 334.65 (-2.09), JNJ: 103.28 (-0.51), ISIS: 65.44 (-2.73), GSK: 41.68 (-0.23)

Jim Cramer: Isis Pharmaceuticals Gets a 'Gigantic' Boost With J&J Deal
at The Street - Mon Jan 05, 10:53AM CST
Cramer says Isis shares are going even higher thanks to a $835 million licensing deal with J&J and a subsidiary.
JNJ: 103.28 (-0.51), ISIS: 65.44 (-2.73), REGN: 396.89 (-15.58)

Today's Market: Biotech Names Rallying, Retail Buyout Candidates
Matthew Smith - at Seeking Alpha - Mon Jan 05, 9:08AM CST

JNJ: 103.28 (-0.51), BBBY: 75.42 (-0.43), ISIS: 65.44 (-2.73), PIR: 14.77 (-0.37), DKS: 49.24 (-0.43), DIA: 173.39 (-1.45), CEMP: 23.15 (-1.40), MAR: 74.67 (-0.95), PCLN: 1,079.96 (-17.62)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Jan 05, 8:10AM CST

CERS: 5.78 (-0.79), E: 32.08 (+0.12), SSL: 34.64 (-0.36), CNAT: 10.63 (+0.57), SDRL: 10.48 (-0.33), NBG: 1.58 (-0.08), BCLI: 5.00 (-0.75), URZ: 1.20 (+0.02), PBR: 6.02 (-0.05), ISIS: 65.44 (-2.73), KITE: 71.45 (+1.70), PLX: 2.02 (-0.15), CEMP: 23.15 (-1.40), STXS: 1.70 (-0.18)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unlock Ingenuity Hits Georgia: Homeowners Rejoice

A Game-Changer for Georgia Homeowners Georgia, your ship might just have come in. The Unlock Home Equity Agreement (HEA) has cornered the market by letting homeowners dip into their home's cash pool without touching their wallets for monthly payments. This means cash in your hands now, in exchange for a share of the home's future value when you decide to wrap it up. It's...

Frasle Mobility's Resilience Despite Market Woes in 3Q26

Economic Wrangling: What Happened? Here comes Frasle Mobility, standing tall against a tide trying to pull everyone under. Ending the third quarter of 2026, they dropped a modest net revenue of R$1.38 billion. A light dip of 1.9% year-over-year, but don't let that fool you. Amid the chaos, these folks managed to expand their gross margin and kept their financials...

SoLo Alpha: Transforming Retail Investment Returns

Pushing Beyond Traditional Financial Constructs In a world where the average Joe is often left holding the short end of the investment stick, SoLo Funds comes charging through with SoLo Alpha, touting a whopping 16% annualized return. They're riding a wave of what seems like a financial revolution, serving up high returns usually reserved for the big fish. It’s hard not...

MyyShop Poised to Redefine the Creator Economy

Breaking Ground in Creator Ecosystems MyyShop isn't just a player in the creator economy; it's trying to change the damned rules. By focusing intensely on co-creation and learning, MyyShop's putting its chips on creating an inclusive and sustainable space where creators aren't just participants but the ones calling the shots. Catalyzing Co-Creation Everybody in the game...

FIS Under Investigation: Legal Woes Hit Shareholders

When Forecasts Falter: A Reality Check for FIS Investors You ever get the feeling a company is just a bit too optimistic? Well, Fidelity National Information Services, Inc. (NYSE: FIS) might've been playing that game up until its recent fiscal hiccup. The mess started on November 4, 2026, when FIS decided to slash its fiscal 2026 adjusted EPS outlook. From a Wall Street...

Medically Supervised Weight Loss: An In-Depth View

Understanding Medical Weight Loss You know, it's high time folks realize that losing weight ain't just about skipping dessert or jogging until you drop. Susan Stivalo, a specialist from Advanced Health and Aesthetics, knows the doughnut from the hole when it comes to tackling weight through medication. The HelloNation article breaks it down: medical weight loss is a...

M-tron Industries Delivers Robust Q3 2026 Performance

Key Takeaways from M-tron's Q3 Results Well, M-tron Industries just put out numbers for Q3 2026 that’ve got the street buzzing. With 11.1% growth in revenues, their top-line performance ain't something to sniff at, especially when the defense and aerospace sectors drive the engine. They're not just coasting on momentum—there's some solid guidance here, with a backlog...

Huawei Shakes Up Home Energy With LUTERRA S2

Welcome to the Future of Home Energy If you thought home energy systems couldn't get any slicker, Huawei's got news for you. They just dropped the LUTERRA S2, a swanky, all-in-one residential energy system that's about to put your old setup to shame. This ain’t your granddad's inverter. We're talking hybrid functionality with storage and AI-driven energy management...

Goranson Bain Ausley Welcomes Marichalar: Family Law Focus

Strengthening San Antonio's Family Law Field Brenda Marichalar is joining the ranks at Goranson Bain Ausley (GBA) with a reputation built on solid courtroom chops and a knack for making clients feel like they’re more than just case numbers. She’s landing right in San Antonio, a region that’s not just about the riverwalks and missions, but about real families...

DFRobot & Sensirion Unveil Cutting-Edge Formaldehyde Sensor

Game-Changing Sensor Technology Hits the Market It's not every day that two heavyweights team up and deliver something that might just shake up an entire sector. That's exactly what's happening with DFRobot and Sensirion's latest joint venture. Launching the SFA40 Formaldehyde Module, these companies are getting down and dirty with air quality detection like never before....